Pregnancy outcome in systemic lupus erythematosus: good news for the new millennium (Q35172091)

6 August 2017

1 reference

title

Pregnancy outcome in systemic lupus erythematosus: good news for the new millennium (English)

1 reference

systemic lupus erythematosus

6 August 2017

0 references

1 reference

Ricard Cervera i Segura

series ordinal

1

object named as

Ricard Cervera

1 reference

6 August 2017

2

Josep Font

1 reference

6 August 2017

4

Juan Balasch

1 reference

6 August 2017

3

Francisco Carmona

1 reference

6 August 2017

1 December 2002

1 reference

6 August 2017

1 reference

6 August 2017

1

1 reference

6 August 2017

6

1 reference

6 August 2017

354-359

1 reference

Association of autoimmune conditions with recurrent intrauterine death.

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Overview of Lupus Pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Antiphospholipid antibodies in unselected patients with repeated abortion

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

The ‘Primary’ Antiphospholipid Syndrome: Antiphospholipid Antibody Pattern and Clinical Features of a Series of 23 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Systemic lupus erythematosus in men: clinical and immunological characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Obstetrical outcome of pregnancy in patients with systemic Lupus erythematosus. A study of 60 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

First international conference on rheumatic diseases in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

The Hopkins Lupus Pregnancy Center: 1987–1991 Update

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Pregnancy does not cause systemic lupus erythematosus to worsen

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Pregnancy in systemic lupus erythematosus: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Obstetric outcome in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Lupus and pregnancy studies

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Systemic lupus erythematosus flares during pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Systemic lupus erythematosus and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Rates of pregnancy outcomes in France

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Pregnancy in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

The effect of aspirin on recurrent fetal loss in experimental antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Reflections on the management of reproductive failure in the antiphospholipid syndrome--the clinician's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

Lupus nephropathy and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900082-4

7 January 2021

10.1016/S1568-9972(02)00082-4

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12848991